HMGB1/SET/HAT1 complex-mediated SASH1 repression drives glycolysis and metastasis in lung adenocarcinoma
F Kou, L Wu, Y Zheng, Y Yi, Z Ji, Z Huang, S Guo… - Oncogene, 2023 - nature.com
High-mobility group box 1 (HMGB1) can enhance the stability and accessibility of nucleus
binding sites to nucleosomes and transcription factors. Recently, HMGB1 has been …
binding sites to nucleosomes and transcription factors. Recently, HMGB1 has been …
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome
T Ramone, C Romei, R Ciampi… - Endocrine-related …, 2023 - erc.bioscientifica.com
Somatic copy number alterations (SCNA) involving either a whole chromosome or just one
of the arms, or even smaller parts, have been described in about 88% of human tumors. This …
of the arms, or even smaller parts, have been described in about 88% of human tumors. This …
Diagnostic Value of GDF10 for the Tumorigenesis and Immune Infiltration in Lung Squamous Cell Carcinoma
X Wang, J Chen, X Qiao, W Meng, Y Wang… - Current Medical …, 2024 - Springer
Objective Lung squamous cell carcinoma (LUSC) is associated with a low survival rate.
Evidence suggests that bone morphogenetic proteins (BMPs) and their receptors (BMPRs) …
Evidence suggests that bone morphogenetic proteins (BMPs) and their receptors (BMPRs) …
[HTML][HTML] Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy
F Kou, L Wu, Y Zhu, B Li, Z Huang, X Ren… - Cancer Gene …, 2022 - nature.com
Somatic copy number alterations (SCNA), which are widespread in cancer, can predict the
efficacy of immune checkpoint inhibitors in non-small-cell lung cancer (NSCLC). However …
efficacy of immune checkpoint inhibitors in non-small-cell lung cancer (NSCLC). However …
